The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Open accessAbstract
Psychostimulants are highly effective in the treatment of attention-deficit/hyperactivity disorder. The clinical efficacy of these drugs is strongly linked to their ability to improve cognition dependent on the prefrontal cortex (PFC) and extended frontostriatal circuit. The procognitive actions of psychostimulants are only associated with low doses. Surprisingly, despite nearly 80 years of clinical use, the neurobiology of the procognitive actions of psychostimulants has only recently been systematically investigated. Findings from this research unambiguously demonstrate that the cognition-enhancing effects of psychostimulants involve the preferential elevation of catecholamines in the PFC and the subsequent activation of norepinephrine α2 and dopamine D1 receptors. In contrast, while the striatum is a critical participant in PFC-dependent cognition, where examined, psychostimulant action within the striatum is not sufficient to enhance cognition. At doses that moderately exceed the clinical range, psychostimulants appear to improve PFC-dependent attentional processes at the expense of other PFC-dependent processes (e.g., working memory, response inhibition). This differential modulation of PFC-dependent processes across dose appears to be associated with the differential involvement of noradrenergic α2 versus α1 receptors. Collectively, this evidence indicates that at low, clinically relevant doses, psychostimulants are devoid of the behavioral and neurochemical actions that define this class of drugs and instead act largely as cognitive enhancers (improving PFC-dependent function). This information has potentially important clinical implications as well as relevance for public health policy regarding the widespread clinical use of psychostimulants and for the development of novel pharmacologic treatments for attention-deficit/hyperactivity disorder and other conditions associated with PFC dysregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DA acts as an inverted U-shaped pattern to cognitive performance. As is reported, too lower or higher DA level elicited by clinically-inappropriate doses of d-amphetamine impairs cognition (12).”
From Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The cognitive-enhancing effects of amphetamine occur through the dopaminergic transmission activation which, in turn, is mediated by both D1 dopamine receptors and α2-adrenoceptors in postsynaptic neurons in PFC [188].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [188]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 1×
“As part of this, the PFC extends topographically organized projections to the striatum (61,62), a region that plays a prominent role in cognitive processes historically associated with the PFC and dysregulation of frontostriatal circuitry is implicated in ADHD (20).”
Balleine, B. W., & O'Doherty, J. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.131 · Cited by 1,775
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,740
Differential projections of the infralimbic and prelimbic cortex in the rat
Vertes, R. P. (2004) · Synapse · doi:10.1002/syn.10279 · Cited by 1,550
Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421
The Role of the Dorsal Striatum in Reward and Decision-Making: Figure 1.
Balleine, B. W., Delgado, M. R., & Hikosaka, O. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1554-07.2007 · Cited by 1,390
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329
Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers
Gabbott, P. L. A., Warner, T. A., Jays, P. R. L., Salway, P., & Busby, S. J. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20738 · Cited by 1,227
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Research works printed but not linked: 1
- Spencer RC, Waterhouse BD, Berridge CW (in press): Neurocircuitry and receptor mechanisms underlying the differential sensitivity of prefrontal cognitive processes to psychostimulants. Soc Neurosci Abst.
Cited by
Sorted by citations
Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work
Westbrook, A., van den Bosch, R., Määttä, J. I., Hofmans, L., Papadopetraki, D., Cools, R., & Frank, M. J. (2020) · Science · doi:10.1126/science.aaz5891 · Cited by 379
Dopamine Does Double Duty in Motivating Cognitive Effort
Westbrook, A., & Braver, T. S. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.029 · Cited by 331
Xing, B., Li, Y.-C., & Gao, W.-J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.005 · Cited by 196
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Sharif, S., Guirguis, A., Fergus, S., & Schifano, F. (2021) · Brain Sciences · doi:10.3390/brainsci11030355 · Cited by 170
Characterizing Attention with Predictive Network Models
Rosenberg, M. D., Finn, E. S., Scheinost, D., Constable, R. T., & Chun, M. M. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.01.011 · Cited by 151
Spatiotemporal dynamics of noradrenaline during learned behaviour
Breton‐Provencher, V., Drummond, G. T., Feng, J., Li, Y., & Sur, M. (2022) · Nature · doi:10.1038/s41586-022-04782-2 · Cited by 151
The costs and benefits of brain dopamine for cognitive control
Cools, R. (2016) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1401 · Cited by 164
Swart, J. C., Froböse, M. I., Cook, J. L., Geurts, D. E. M., Frank, M. J., Cools, R., & den Ouden, H. E. M. (2017) · eLife · doi:10.7554/elife.22169 · Cited by 140
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
da Silva, B. S., Grevet, E. H., Silva, L. C. F., Ramos, J. K. N., Rovaris, D. L., & Bau, C. H. D. (2023) · Discover Mental Health · doi:10.1007/s44192-022-00030-1 · Cited by 146
Methylphenidate Modulates Functional Network Connectivity to Enhance Attention
Rosenberg, M. D., Zhang, S., Hsu, T. W., Scheinost, D., Finn, E. S., Shen, X., Constable, R. T., Li, C. R., & Chun, M. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1746-16.2016 · Cited by 113
Berridge, C. W., & Spencer, R. C. (2016) · Brain Research · doi:10.1016/j.brainres.2015.11.024 · Cited by 112
Self-citationRegion-Specific Dissociation between Cortical Noradrenaline Levels and the Sleep/Wake Cycle
Bellesi, M., Tononi, G., Cirelli, C., & Serra, P. A. (2015) · SLEEP · doi:10.5665/sleep.5336 · Cited by 80
Quintero, J., Gutiérrez-Casares, J. R., & Álamo, C. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00392-2 · Cited by 70
“However, the MPH effects on these signalling pathways were totally inhibited using ADRD1B blockers, showing that ADRD1B mediates the phosphorylation of PKA signalling through MPH in the PFC [143].”
BackgroundInfluentialCurrent Pharmacological Treatments for ADHD
Groom, M. J., & Cortese, S. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_330 · Cited by 74
Dunn, M., Henke, A., Clark, S. D., Kovalyova, Y., Kempadoo, K. A., Karpowicz, R. J., Kandel, E. R., Sulzer, D., & Sameš, D. (2018) · Nature Communications · doi:10.1038/s41467-018-05075-x · Cited by 65
International society of sports nutrition position stand: tactical athlete nutrition
Gonzalez, D. E., McAllister, M. J., Waldman, H. S., Ferrando, A. A., Joyce, J., Barringer, N., Dawes, J. J., Kieffer, A. J., Harvey, T. M., Kerksick, C. M., et al. (2022) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2022.2086017 · Cited by 76
Onaolapo, A. Y., Obelawo, A. Y., & Onaolapo, O. J. (2019) · Current Aging Science · doi:10.2174/1874609812666190311160754 · Cited by 62
Specificity and impact of adrenergic projections to the midbrain dopamine system
Mejías-Aponte, C. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.036 · Cited by 58
Drugs, games, and devices for enhancing cognition: implications for work and society
Brühl, A. B., & Sahakian, B. J. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13040 · Cited by 58
Hupalo, S., Martin, A. J., Green, R. K., Devilbiss, D. M., & Berridge, C. W. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2701-18.2019 · Cited by 44
Self-citationCatecholaminergic modulation of the avoidance of cognitive control.
Froböse, M. I., Swart, J. C., Cook, J. L., Geurts, D. E. M., den Ouden, H. E. M., & Cools, R. (2018) · Journal of Experimental Psychology General · doi:10.1037/xge0000523 · Cited by 53
The role of the locus coeruleus in shaping adaptive cortical melodies
Wainstein, G., Müller, E. J., Taylor, N. L., Munn, B., & Shine, J. M. (2022) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.03.006 · Cited by 47
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
Scheggia, D., Mastrogiacomo, R., Mereu, M., Sannino, S., Straub, R. E., Armando, M., Managò, F., Guadagna, S., Piras, F., Zhang, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04711-w · Cited by 44
Garasic, M. D., & Lavazza, A. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0102-8 · Cited by 41
Dopamine Promotes Cognitive Effort by Biasing the Benefits Versus Costs of Cognitive WorkPreprint
Westbrook, A., van den Bosch, R., Määttä, J. I., Hofmans, L., Papadopetraki, D., Cools, R., & Frank, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/778134 · Cited by 41
Becker, M., Repantis, D., Dresler, M., & Kühn, S. (2022) · Human Brain Mapping · doi:10.1002/hbm.25949 · Cited by 46
Angeli, A., Vaiano, F., Mari, F., Bertol, E., & Supuran, C. T. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1375485 · Cited by 36
van den Bosch, R., Lambregts, B., Määttä, J. I., Hofmans, L., Papadopetraki, D., Westbrook, A., Verkes, R., Booij, J., & Cools, R. (2022) · Nature Communications · doi:10.1038/s41467-022-32679-1 · Cited by 33
Song, Y., Yuan, H., Chen, T., Lu, M., Shuang, L., & Han, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.617581 · Cited by 30
Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants
Spencer, R. C., & Berridge, C. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0314-y · Cited by 31
Self-citationNilsson, S. R. O., Heath, C. J., Takillah, S., Didienne, S., Fejgin, K., Nielsen, V., Nielsen, J., Saksida, L. M., Mariani, J., Fauré, P., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0295-3 · Cited by 31
Probing the structure and function of locus coeruleus projections to CNS motor centers
Waterhouse, B. D., Predale, H. K., Plummer, N. W., Jensen, P., & Chandler, D. J. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.895481 · Cited by 29
Ruf, B. M., Bessette, K. L., Pearlson, G. D., & Stevens, M. C. G. (2016) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2016.1232373 · Cited by 34
Adisetiyo, V., Gray, K. M., Jensen, J. H., & Helpern, J. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101993 · Cited by 30
Mørk, A., Russell, R. V., de Jong, I. E. M., & Smagin, G. N. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.010 · Cited by 27
Borragán, G., Gilson, M., Guerrero-Mosquera, C., Ricci, E. D., Slama, H., & Peigneux, P. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02351 · Cited by 29
Stress Degrades Prefrontal Cortex Neuronal Coding of Goal-Directed Behavior
Devilbiss, D. M., Spencer, R. C., & Berridge, C. W. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw140 · Cited by 30
Self-citationHiggins, G. A., Silenieks, L. B., MacMillan, C., Thevarkunnel, S., Parachikova, A. I., Mombereau, C., Lindgren, H. S., & Bastlund, J. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00427 · Cited by 26
Light, S. N., Bieliauskas, L. A., & Zubieta, J. (2017) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16090171 · Cited by 24
Awuchi, C. G., Aja, P. M., Mitaki, N. B., Morya, S., Amagwula, I. O., Echeta, C. K., & Igwe, V. S. (2023) · Journal of Chemistry · doi:10.1155/2023/5852315 · Cited by 27
Berridge, C., & Arnsten, A. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.01.002 · Cited by 24
Self-citationÖğüt, E., Akçay, G., Yıldırım, F. B., Derin, N., & Aslan, M. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1849191 · Cited by 22
Wilke, S. A., Johnson, C. L., Corlier, J., Marder, K. G., Wilson, A. C., Pleman, C. M., & Leuchter, A. F. (2022) · Depression and Anxiety · doi:10.1002/da.23255 · Cited by 22
Stress Response, Brain Noradrenergic System and Cognition
Winklewski, P. J., Radkowski, M., Wszędybył-Winklewska, M., & Demkow, U. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_204 · Cited by 23
Comparative biology of sleep in diverse animals
Lakhiani, R., Shanavas, S., & Melnattur, K. V. (2023) · Journal of Experimental Biology · doi:10.1242/jeb.245677 · Cited by 20
The effects of dexamphetamine on the resting‐state electroencephalogram and functional connectivity
Albrecht, M. A., Roberts, G., Price, G. W., Lee, J., Iyyalol, R., & Martin-Iverson, M. T. (2015) · Human Brain Mapping · doi:10.1002/hbm.23052 · Cited by 23
Um, Y. H., Jeong, J., Hong, S., Kim, T., Lim, H. K., Seo, H., & Han, J. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.11.016 · Cited by 22
Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
Mandali, A., Sethi, A., Cercignani, M., Harrison, N. A., & Voon, V. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01118-4 · Cited by 18
Salman, T., Afroz, R., Nawaz, S., Mahmood, K., Haleem, D. J., & Zarina, S. (2021) · Biochimie · doi:10.1016/j.biochi.2021.08.009 · Cited by 18
Benn, A., & Robinson, E. S. J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4458-8 · Cited by 19
Alam, N., & Choudhary, K. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0190-x · Cited by 20
Silveira, M. M., Murch, W. S., Clark, L., & Winstanley, C. A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000203 · Cited by 22
Dai, H., Goto, Y., & Itoh, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.10.011 · Cited by 19
Mucci, F., Avella, M. T., & Marazziti, D. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190805153610 · Cited by 21
Analysis of six ‘neuro‐enhancing’ phenidate analogs
Klare, H., Neudörfl, J., Brandt, S. D., Mischler, E., Meier‐Giebing, S., Deluweit, K., Westphal, F., & Laußmann, T. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2161 · Cited by 18
In search of optimal psychoactivation: stimulants as cognitive performance enhancers
Rozenek, E. B., Górska, M., Wilczyńska, K., & Waszkiewicz, N. (2019) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/aiht-2019-70-3298 · Cited by 18
The cognitive and behavioral effects of D-amphetamine and nicotine sensitization in adult zebrafish
Cleal, M., Fontana, B. D., & Parker, M. O. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05844-5 · Cited by 20
Hino, K., Kaneko, S., Harasawa, T., Kimura, T., Takei, S., Shinohara, M., Yamazaki, F., Morita, S., Sato, S., Kubo, Y., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2721-18.2019 · Cited by 17
Matzel, L. D., & Sauce, B. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1060786 · Cited by 17
Pre-trauma Methylphenidate in rats reduces PTSD-like reactions one month later
Ritov, G., & Richter‐Levin, G. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.277 · Cited by 17
Assessing Critical Flicker Fusion Frequency: Which Confounders? A Narrative Review
Muth, T., Schipke, J. D., Brebeck, A.-K., & Dreyer, S. (2023) · Medicina · doi:10.3390/medicina59040800 · Cited by 16
Silberstein, R. B., Lévy, F., Pipingas, A., & Farrow, M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.022 · Cited by 16
Sterley, T.-L., Howells, F. M., Dimatelis, J. J., & Russell, V. A. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9742-5 · Cited by 16
Pillidge, K., Porter, A. J., Young, J. W., & Stanford, S. C. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116642541 · Cited by 17
Aasen, I. E., Øgrim, G., Kropotov, J. D., & Brunner, J. F. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2018.02.011 · Cited by 15
Tremblay, S., Pieper, F., Sachs, A. J., Joober, R., & Martínez-Trujillo, J. (2019) · eNeuro · doi:10.1523/eneuro.0371-18.2018 · Cited by 15
Zammit, N., & Muscat, R. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14398 · Cited by 14
Wang, P., Yan, F., Dong, J., Wang, S., Shi, Y., Zhu, M., Zuo, Y., Ma, H., Xue, R., Zhai, D., et al. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp05676c · Cited by 14
Lifetime evolution of ADHD treatment
Mucci, F., Carpita, B., Pagni, G., Vecchia, A. D., Bjedov, S., Pozza, A., & Marazziti, D. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02336-w · Cited by 15
Dort, C. J. V. (2015) · SLEEP · doi:10.5665/sleep.5302 · Cited by 15
The Inert Brain: Explaining Neural Inertia as Post-anaesthetic Sleep Inertia
Luppi, A. I., Spindler, L. R. B., Menon, D. K., & Stamatakis, E. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.643871 · Cited by 15
Pinterová, N., Horsley, R. R., Danda, H., Žídková, M., Lhotková, E., Šíchová, K., Štefková, K., Balı́ková, M., Kuchař, M., & Páleníček, T. (2020) · Addiction Biology · doi:10.1111/adb.12906 · Cited by 13
R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity
Shanmugasundaram, B., Aher, Y. D., Lubec, J., Ilic, M., Feyissa, D. D., Kalaba, P., Aher, N. Y., Dragačević, V., Sabermarouf, B., Langer, T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179675 · Cited by 14
Evidence for a role of corticopetal, noradrenergic systems in the development of executive function
Mokler, D. J., Miller, C. E., & McGaughy, J. A. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.02.011 · Cited by 12
Palamar, J. J., & Le, A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.033 · Cited by 13
Bardgett, M. E., Crane, C., Thompson, E. C. B., Cox, B., & Downnen, T. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.044 · Cited by 13
Cénat, J. M., Kogan, C. S., Kebedom, P., Ukwu, G., Farahi, S. M. M. M., Darius, W. P., Bakombo, S. M., Dalexis, R. D., Ndengeyingoma, A., Noorishad, P., et al. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107567 · Cited by 12
PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice
Betti, A. H., Antonio, C. B., Herzfeldt, V., Pitta, M. G. D. R., Pitta, I. D. R., do Rego, J. L., do-Rego, J.-C., Vaudry, D., & Rates, S. M. K. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000494 · Cited by 12
The effects of the prodrug Vyvanse on spatial working memory and adiposity in rats
Ekstrand, E., Murphy, H. M., & Wideman, C. H. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172765 · Cited by 12
Peters, M. S., Park, C. H. J., Turner, A., Guerin, A. A., & Kim, J. H. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100064 · Cited by 11
Potentiation of prefrontal cortex dopamine function by the novel cognitive enhancer d-govadine
Nesbit, M. O., Ahn, S., Zou, H., Floresco, S., & Phillips, A. G. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109849 · Cited by 11
Li, Y., Wang, S., Guo, L., Zhu, J., Wang, Y., Li, L., & Zhao, Y. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.218025 · Cited by 11
McBurney-Lin, J., Sun, Y., Tortorelli, L. S., Nguyen, Q. A. T., Haga‐Yamanaka, S., & Yang, H. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108151 · Cited by 11
Mishra, S. K., Chaudhary, V., Saraswathy, K. N., Shekhawat, L. S., & Devi, N. K. (2024) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-024-02697-z · Cited by 10
Takım, U., Belli, H., Gökçay, H., Köse, H., Akgül, H. A., & Çakır, A. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2024.241630 · Cited by 10
The possible role of air pollution in the link between ADHD and obesity
Fluegge, K. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1189802 · Cited by 10
Iwaki, H., Tagawa, M., Iwasaki, K., Kawakami, K., & Nomoto, M. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.05.028 · Cited by 10
Nishikura, N., Hino, K., Kimura, T., Uchimura, Y., Hino, S., Nakao, M., Maruo, Y., & Udagawa, J. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz237 · Cited by 9
Bernhardt, L. K., Bairy, K. L., & Madhyastha, S. (2018) · Brain Sciences · doi:10.3390/brainsci8070120 · Cited by 10
Lubec, J., Hussein, A. M., Kalaba, P., Feyissa, D. D., Arias‐Sandoval, E., Cybulska-Kłosowicz, A., Bezu, M., Stojanovic, T., Korz, V., Maliković, J., et al. (2023) · Biomolecules · doi:10.3390/biom13030467 · Cited by 9
de Oliveira, L. G., Barroso, L. P., Leopoldo, K., Gouvêa, M. J. C., Castaldelli-Maia, J. M., & Leyton, V. (2019) · Transportation Research Part F Traffic Psychology and Behaviour · doi:10.1016/j.trf.2019.11.018 · Cited by 9
Selective Visual Attention in ADHD: A Narrative Review
Klein, J. L., Allen, H. A., Clibbens, J., Cook, A., Amanatidou, V., & Mavritsaki, E. (2025) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-025-01435-5 · Cited by 10
Varga, T. G., Simões, J. G. D. T., Siena, A., Henrique, E., da Silva, R. C. B., Bioni, V. S., Ramos, A. C., & Rosenstock, T. R. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05880-1 · Cited by 9
Guo, J., Luo, X., Kong, Y., Li, B., Si, B., Jensen, O. B., Sun, L., & Song, Y. (2022) · Biological Psychology · doi:10.1016/j.biopsycho.2022.108481 · Cited by 10
Yang, X., & Geng, F. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25238 · Cited by 9
Carvallo, C., Contreras, D., Ugarte, G., Delgado, R., Pancetti, F. C., Rozas, C., Piña, R., Constandil, L., Zeise, M. L., & Morales, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01485 · Cited by 8
Gorka, A. X., Lago, T. R., Balderston, N. L., Torrisi, S., Fuchs, B. A., Grillon, C., & Ernst, M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05505-z · Cited by 9
Jian-min, C., Zhi-yuan, W., Shi-xuan, W., Rui, S., Ning, W., & Jin, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.885574 · Cited by 7
“As is reported, too lower or higher DA level elicited by clinicallyinappropriate doses of d-amphetamine impairs cognition (12).”
BackgroundA Dopamine D1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory
Yang, Y., Lewis, M. M., Kong, L., & Mailman, R. B. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001215 · Cited by 7
Sagheddu, C., Cancedda, E., Bagheri, F., Kalaba, P., Muntoni, A. L., Lubec, J., Lübec, G., Sanna, F., & Pistis, M. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad056 · Cited by 7
Metadata
- Authors
- Spencer, R. C., Devilbiss, D. M., & Berridge, C. W.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Berridge, Craig W.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 77
- Issue
- 11
- Pages
- 940-950
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC4377121
- OpenAlex
- W2080244900
- Cited by
- 164
- References
- 108
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 8 · 2023: 15 · 2022: 18 · 2021: 22 · 2020: 9 · 2019: 20 · 2018: 13 · 2017: 17 · 2016: 14 · 2015: 8
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Rowan Digitals Works (Rowan University) (submittedVersion, cc-by-nc-nd)
- Funders
- Public Health Service (MH098631, MH081843, DA000389)
- National Science Foundation (NSF 0918555)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- psychostimulants, cognitive enhancement, prefrontal cortex, attention deficit hyperactivity disorder, catecholamines, dopamine D1 receptor, striatum, frontostriatal circuits, dose-dependent effects, working memory, response inhibition, attention
- MeSH terms
- Central Nervous System Stimulants, Animals, Cognition, Humans, Prefrontal Cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review